文献速递脑血管病

中等血管闭塞性卒中的血管内治疗

Endovascular Treatment of Medium Vessel Occlusion Stroke.
PubMed 文献 · Stroke · 2024-01-18

约三分之一的急性缺血性卒中由中等血管闭塞(MeVO)引起,管理具有挑战性。药物治疗的临床病程并非良性,但较大血管闭塞更有利;血管内治疗并发症率更高,边际获益可能更小且更难检测。多项随机对照试验正在进行,将为MeVO血管内治疗决策提供可靠数据。本文综述MeVO定义、影像检测优化策略及血管内治疗决策考虑。

要点

  • 约三分之一的急性缺血性卒中由可识别的中等血管闭塞引起。
  • MeVO检测具有挑战性,在繁忙临床常规中有时未被诊断。
  • MeVO药物治疗的临床病程并非良性,但较大血管闭塞更有利。

核心结论

  • MeVO血管内治疗的边际获益预计较小且更难检测,多项随机对照试验正在进行以提供可靠数据。

研究设计与样本

  • 综述,讨论MeVO定义、影像检测优化策略及血管内治疗决策考虑,并概述正在进行的MeVO血管内治疗试验。

主要发现

  • 约三分之一的急性缺血性卒中由可识别的中等血管闭塞引起。
  • MeVO检测具有挑战性,尤其对经验不足的医师,在繁忙临床常规中有时未被诊断。
  • MeVO药物治疗的临床病程并非良性,但较大血管闭塞更有利。
  • MeVO血管内治疗并发症率更高,边际获益预计更小且更难检测。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Approximately one-third of acute ischemic strokes with an identifiable vessel occlusion are caused by medium vessel occlusion (MeVO), that is, nonlarge vessel occlusions that are potentially amenable to endovascular treatment (EVT). Management of patients with MeVO is challenging in many ways: detecting MeVOs can be challenging, particularly for inexperienced physicians, and in busy clinical routine, MeVOs, therefore, remain sometimes undiagnosed. While the clinical course of MeVO stroke with medical management, including intravenous thrombolysis, is by no means, benign, it is more favorable compared with large vessel occlusion. At the same time, EVT complication rates are higher, and thus, the marginal benefit of EVT beyond best medical management is expected to be smaller and more challenging to detect if it were present. Several randomized controlled trials are currently underway to investigate whether and to what degree patients with MeVO may benefit from EVT and will soon provide robust data for evidence-based MeVO EVT decision-making. In this review, we discuss different ways of defining MeVOs, strategies to optimize MeVO detection on imaging, and considerations for EVT decision-making in the setting of MeVO stroke. We discuss the technical challenges related to MeVO EVT and conclude with an overview of currently ongoing MeVO EVT trials.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ospel JM, Nguyen TN, Jadhav AP, et al. Endovascular Treatment of Medium Vessel Occlusion Stroke. Stroke. 2024. PMID: 38235587. doi:10.1161/STROKEAHA.123.036942

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。